Amgen, Allergan biosimilar of Roche's blockbuster Rituxan clears another US pivotal study

Novartis $NVS may have given up, but Amgen $AMGN and Allergan $AGN are plowing ahead with their knockoff of Roche’s blockbuster biologic Rituxan in the United States.